Antiplatelet therapy after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk.
Nowell
Justin
J
Jahangiri
Marjan
M
D001021:Aortic Valve / Q000601:surgery*; D001705:Bioprosthesis; D019317:Evidence-Based Medicine; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011182:Postoperative Care / Q000379:methods; D019564:Unnecessary Procedures
D010975:Platelet Aggregation Inhibitors